Skip to main navigation Skip to search Skip to main content

The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children: a Prospective, Randomized Crossover Trial

Press/Media: Research

PeriodApr 8 2025

Media coverage

1

Media coverage

  • TitleThe Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children: a Prospective, Randomized Crossover Trial
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date4/8/25
    PersonsXiaoming Wang
View all 1
View less